Prenetics Group Limited (PRE): Price and Financial Metrics Recent IPO


Prenetics Group Limited (PRE): $3.95

-0.02 (-0.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PRE Stock Price Chart Interactive Chart >

Price chart for PRE

PRE Price/Volume Stats

Current price $3.95 52-week high $8.75
Prev. close $3.97 52-week low $3.39
Day low $3.92 Volume 34,100
Day high $4.02 Avg. volume 105,541
50-day MA $4.15 Dividend yield N/A
200-day MA $0.00 Market Cap 173.48M

Prenetics Group Limited (PRE) Company Bio


Prenetics Group Limited operates as a diagnostics and genetic testing company worldwide. It develops consumer genetic testing and early colorectal cancer screening products; and provides COVID-19 testing, rapid point of care and at-home diagnostic testing, and medical genetic testing products. The company's products include CircleDNA, a consumer genetic testing offering that uses whole exome sequencing; Project Screen, a COVID-19 test; and Circle HealthPod, a molecular testing product for COVID-19. It is also developing ColoClear, a non-invasive stool-based FIT-DNA test for colorectal cancer screening; Circle SnapShot, an at-home blood test with a user-friendly blood sample collection and result delivery system; Circle Medical, a test to identify causal genetic mutations for patients; and Circle One and F1x/Fem, a DNA profile and questionnaire based personalized nutrition solution. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.


PRE Latest News Stream


Event/Time News Detail
Loading, please wait...

PRE Latest Social Stream


Loading social stream, please wait...

View Full PRE Social Stream

PRE Price Returns

1-mo -0.50%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.3951 seconds.